US Patent 11840710 Methods for purification of recombinant AAV vectors
Patent 11840710 was granted and assigned to Genzyme on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+410 characters)
US Patent 11840710 Methods for purification of recombinant AAV vectors
Article
Patent abstract
Provided herein are methods for the purification of recombinant adeno-associated virus (rAAV) vectors that can be used for gene transfer and specifically for gene therapy or vaccination. Recombinant AAV vectors of the invention are substantially free of in-process impurities, including production components such as cellular nucleic acids, cellular proteins, helper virus, and media components.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Barbara A. Thorne0
Gina Nichols0
Paulene McLean Quigley Sheldon0
Peter S. Gagnon0
Date of Patent
December 12, 2023
0Patent Application Number
170354800
Date Filed
September 28, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11840710 Methods for purification of recombinant AAV vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
